Table 1.

Clinical characteristics of genotyped populations

	T2DN cases n = 203	T2DN controls n = 246	T1DN cases n = 718	T1DN controls n = 749
Age at diagnosis of diabetes (years)	51.6 ± 11.9	51.2 ± 9.7	14.8 ± 7.7	15.4 ± 8.0
Duration of diabetes (years)	15.2 ± 8.4	14.6 ± 6.4	34.5 ± 9.6	29.6 ± 9.1
a,b HbA1c (%)	10.2 ± 1.7	10.0 ± 1.4	8.8 ± 1.8	8.6 ± 1.5
BMI (kg/m2)	31.5 ± 6.6	30.7 ± 6.3	26.2 ± 5.0	26.1 ± 4.2
a Systolic BP (mmHg)	147 ± 20	140 ± 18	145 ± 21	125 ± 15
a Diastolic BP (mmHg)	76 ± 11	75 ± 10	82 ± 11	75 ± 8

Data are mean ± SD

^avalues are based on the average of the most recent three measurements for each individual

^bDCCT (Diabetes Control and Complications Trial) aligned assay for hemoglobin A1c